Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,159 | 2,169 | 491 | 1,235 | 2,973 |
| Gross Profit | 1,159 | 2,169 | 491 | 1,235 | 2,973 |
| Operating Expenses | 8,935 | 9,013 | 8,682 | 11,773 | 12,729 |
| Operating Income | -7,776 | -6,844 | -8,191 | -10,538 | -9,756 |
| Interest Expense | 4,346 | 3,808 | 3,602 | 3,281 | 2,923 |
| Other Income | -14,553 | -5,643 | 5,262 | 16,419 | 7,198 |
| Pre-tax Income | -26,675 | -16,295 | -6,531 | 2,600 | -5,481 |
| Net Income Continuous | -26,675 | -16,295 | -6,531 | 2,600 | -5,481 |
| Net Income | $-26,675 | $-16,295 | $-6,531 | $2,600 | $-5,481 |
| EPS Basic Total Ops | -0.74 | -0.45 | -0.18 | 0.07 | -0.15 |
| EPS Basic Continuous Ops | -0.74 | -0.45 | -0.18 | 0.07 | -0.15 |
| EPS Diluted Total Ops | -0.74 | -0.45 | -0.20 | 0.20 | -0.15 |
| EPS Diluted Continuous Ops | -0.74 | -0.45 | -0.11 | 0.37 | -0.15 |
| EPS Diluted Before Non-Recurring Items | -0.42 | -0.32 | -0.20 | -0.23 | -0.15 |
| EBITDA(a) | $-7,406 | $-6,478 | $-7,814 | $-10,158 | $-9,443 |